バイオテクノロジーサービス市場：サービスタイプ別、エンドユーザー別-2025～2030年の世界予測

バイオテクノロジーサービス市場は、2023年に1,930億5,000万米ドルと評価され、2024年には2,146億9,000万米ドルに達すると予測され、CAGR 11.60％で成長し、2030年には4,162億5,000万米ドルに達すると予測されています。

バイオテクノロジーサービス市場は、バイオプロセス、創薬、DNAシーケンシング、ゲノミクス、プロテオミクスなど、ライフサイエンス企業の支援や医療ソリューションの向上を目的とした幅広いサービスを包含しています。これらのサービスの必要性は、個別化医療に対する需要の高まり、バイオ医薬品における画期的な進歩、革新的な医療ソリューションに対する差し迫ったニーズから生じています。これらのサービスは、研究、前臨床検査から規制当局の承認、市販後調査まで、医薬品・バイオテクノロジー製品開発のさまざまな段階にわたって適用され、研究機関、医療プロバイダー、製薬会社などの組織をサポートしています。この市場の主要成長要因としては、遺伝子工学の進歩、バイオテクノロジー研究開発への旺盛な投資、革新的治療を必要とする慢性疾患の蔓延などが挙げられます。CRISPR技術、再生医療、バイオインフォマティクスなどのセグメントにはビジネス機会があふれています。利害関係者は、共同パートナーシップへの投資、サービス・ポートフォリオの強化、新興市場への注力を行うことで、これらを活用することができます。とはいえ、厳しい規制状況、高い運用コスト、遺伝子組み換えをめぐる倫理的懸念など、市場拡大の妨げとなる限界も存在します。さらに、熟練した専門家へのアクセスやデータ管理の課題も大きなハードルとなっています。事業成長の可能性が高い革新的な研究開発セグメントとしては、手頃な価格のシーケンシング手法の開発、バイオプロセスの効率化、創薬における予測分析のためのAIと機械学習の統合などが挙げられます。市場参入企業や既存企業にとって、市場力学の考察から、有望ではあるが競合情勢が明らかになり、持続的成長には適応力、技術力、戦略的提携が不可欠となります。また、患者中心のアプローチと持続可能性の実践を重視することで、環境に配慮した人間中心の医療ソリューションという世界の動向に沿った明確な利点が得られる可能性があります。全体として、バイオテクノロジーサービス市場は、革新的な戦略で複雑な状況を乗り切る準備ができている人々にとって、可能性に満ちた活気に満ちた環境です。

市場力学：急速に進化するバイオテクノロジーサービス市場の主要市場洞察を公開

バイオテクノロジーサービス市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネス機会の獲得に備えることができます。こうした動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 製薬企業による医薬品開発業務のアウトソーシングの増加
  • 学術研究活動の活発化と効率的な施設の必要性
  • 受託研究・製造サービスの拡大の高まり
• 市場抑制要因
  • アウトソーシングサービスのパフォーマンス、品質、機密性に対する懸念
• 市場機会
  • バイオテクノロジー機器と技術の進歩
  • バイオテクノロジー研究における資金調達と投資活動の活発化
• 市場課題
  • バイオテクノロジーのアウトソーシングサービスに対する厳しい規制遵守事項

ポーターのファイブフォース：バイオテクノロジーサービス市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を把握するための重要なツールです。ポーターのファイブフォースフレームワークは、企業の競合を評価し、戦略的機会を探るための明確な手法を記載しています。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これら洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：バイオテクノロジーサービス市場における外部からの影響の把握

外部マクロ環境要因は、バイオテクノロジーサービス市場の業績力学を形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を記載しています。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析：バイオテクノロジーサービス市場における競合情勢の把握

バイオテクノロジーサービス市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、セグメント化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的な意思決定を行うために必要な知見を得ることができます。

FPNVポジショニングマトリックスバイオテクノロジーサービス市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、バイオテクノロジーサービス市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨：バイオテクノロジーサービス市場における成功への道筋を描く

バイオテクノロジーサービス市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を検討することで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネス機会を活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目セグメントを網羅した市場の包括的な分析を提供しています。

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存セグメントにおける拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを記載しています。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発とイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています。

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、地域はどこか？

3.市場を形成する主要技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 製薬会社による医薬品開発業務のアウトソーシングの増加
    • 学術研究活動の増加と効率的な施設の必要性
    • 受託研究・製造サービスの拡大
  • 抑制要因
    • アウトソーシングサービスのパフォーマンス、品質、機密性に関する懸念
  • 機会
    • バイオテクノロジー機器と技術の進歩
    • バイオテクノロジー調査における新たな資金調達と投資活動
  • 課題
    • バイオテクノロジーアウトソーシングサービスに対する厳格な規制遵守
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治
  • 経済
  • 社会
  • 技術
  • 法律
  • 環境

第6章 バイオテクノロジーサービス市場：サービスタイプ別

• イントロダクション
• 細胞処理と分離
• ドナーの募集
• 食品バイオテクノロジーサービス
• 予防と疾病管理
• 公共エンゲージメント活動
• 組織採取

第7章 バイオテクノロジーサービス市場：エンドユーザー別

• イントロダクション
• バイオテクノロジー企業
• 臨床研究機関（CRO）
• 契約製造業者組織（CMO）

第8章 南北アメリカのバイオテクノロジーサービス市場

• イントロダクション
• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第9章 アジア太平洋のバイオテクノロジーサービス市場

• イントロダクション
• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第10章 欧州・中東・アフリカのバイオテクノロジーサービス市場

• イントロダクション
• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第11章 競合情勢

• 市場シェア分析、2023年
• FPNVポジショニングマトリックス、2023年
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Agilent Technologies, Inc.
• Almac Group Limited
• AnaBioTec NV
• Avance Clinical Pty Ltd.
• Azenta Life Sciences
• Becton, Dickinson and Company
• Biogen Inc.
• BioIVT LLC
• Caidya
• Catalent, Inc.
• Charles River Laboratories International, Inc.
• CMIC Group
• Contract Pharmacal Corp.
• Crown Bioscience, Inc.
• Danaher Corporation
• Eurofins Scientific Limited
• GE HealthCare Technologies Inc.
• GenScript BIoTech Corporation
• ICON PLC
• ITR Laboratories Canada
• Kaneka Corporation
• Laboratory Corporation of America Holdings
• Merck KGaA
• Novartis AG
• Siemens Healthcare GmbH
• Thermo Fisher Scientific Inc.

LIST OF FIGURES

• FIGURE 1. BIOTECHNOLOGY SERVICES MARKET RESEARCH PROCESS
• FIGURE 2. BIOTECHNOLOGY SERVICES MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USERS, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USERS, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. AMERICAS BIOTECHNOLOGY SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 11. AMERICAS BIOTECHNOLOGY SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. UNITED STATES BIOTECHNOLOGY SERVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 13. UNITED STATES BIOTECHNOLOGY SERVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. ASIA-PACIFIC BIOTECHNOLOGY SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. ASIA-PACIFIC BIOTECHNOLOGY SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. EUROPE, MIDDLE EAST & AFRICA BIOTECHNOLOGY SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA BIOTECHNOLOGY SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. BIOTECHNOLOGY SERVICES MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 19. BIOTECHNOLOGY SERVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. BIOTECHNOLOGY SERVICES MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. BIOTECHNOLOGY SERVICES MARKET DYNAMICS
• TABLE 7. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY CELL PROCESSING & ISOLATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY DONOR RECRUITMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY FOOD BIOTECHNOLOGY SERVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY PREVENTION & DISEASE CONTROL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY PUBLIC ENGAGEMENT ACTIVITIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY TISSUE COLLECTION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY CLINICAL RESEARCH ORGANIZATIONS(CROS), BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL BIOTECHNOLOGY SERVICES MARKET SIZE, BY CONTRACT MANUFACTURERS ORGANIZATIONS (CMOS), BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. AMERICAS BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 19. AMERICAS BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 20. AMERICAS BIOTECHNOLOGY SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 21. ARGENTINA BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 22. ARGENTINA BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 23. BRAZIL BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 24. BRAZIL BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 25. CANADA BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 26. CANADA BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 27. MEXICO BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 28. MEXICO BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 29. UNITED STATES BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 30. UNITED STATES BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 31. UNITED STATES BIOTECHNOLOGY SERVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 32. ASIA-PACIFIC BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 33. ASIA-PACIFIC BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 34. ASIA-PACIFIC BIOTECHNOLOGY SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 35. AUSTRALIA BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 36. AUSTRALIA BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 37. CHINA BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 38. CHINA BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 39. INDIA BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 40. INDIA BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 41. INDONESIA BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 42. INDONESIA BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 43. JAPAN BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 44. JAPAN BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 45. MALAYSIA BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 46. MALAYSIA BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 47. PHILIPPINES BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 48. PHILIPPINES BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 49. SINGAPORE BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 50. SINGAPORE BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 51. SOUTH KOREA BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 52. SOUTH KOREA BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 53. TAIWAN BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 54. TAIWAN BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 55. THAILAND BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 56. THAILAND BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 57. VIETNAM BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 58. VIETNAM BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 59. EUROPE, MIDDLE EAST & AFRICA BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 60. EUROPE, MIDDLE EAST & AFRICA BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 61. EUROPE, MIDDLE EAST & AFRICA BIOTECHNOLOGY SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 62. DENMARK BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 63. DENMARK BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 64. EGYPT BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 65. EGYPT BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 66. FINLAND BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 67. FINLAND BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 68. FRANCE BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 69. FRANCE BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 70. GERMANY BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 71. GERMANY BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 72. ISRAEL BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 73. ISRAEL BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 74. ITALY BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 75. ITALY BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 76. NETHERLANDS BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 77. NETHERLANDS BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 78. NIGERIA BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 79. NIGERIA BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 80. NORWAY BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 81. NORWAY BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 82. POLAND BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 83. POLAND BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 84. QATAR BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 85. QATAR BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 86. RUSSIA BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 87. RUSSIA BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 88. SAUDI ARABIA BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 89. SAUDI ARABIA BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 90. SOUTH AFRICA BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 91. SOUTH AFRICA BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 92. SPAIN BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 93. SPAIN BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 94. SWEDEN BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 95. SWEDEN BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 96. SWITZERLAND BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 97. SWITZERLAND BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 98. TURKEY BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 99. TURKEY BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 100. UNITED ARAB EMIRATES BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 101. UNITED ARAB EMIRATES BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 102. UNITED KINGDOM BIOTECHNOLOGY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 103. UNITED KINGDOM BIOTECHNOLOGY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 104. BIOTECHNOLOGY SERVICES MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 105. BIOTECHNOLOGY SERVICES MARKET, FPNV POSITIONING MATRIX, 2023

The Biotechnology Services Market was valued at USD 193.05 billion in 2023, expected to reach USD 214.69 billion in 2024, and is projected to grow at a CAGR of 11.60%, to USD 416.25 billion by 2030.

The Biotechnology Services market encompasses a wide range of services such as bioprocessing, drug discovery, DNA sequencing, genomics, and proteomics, aimed at supporting life sciences companies and advancing healthcare solutions. The necessity for these services arises from the increasing demand for personalized medicine, breakthroughs in biopharmaceuticals, and the pressing need for innovative healthcare solutions. These services are applied across various stages of pharmaceutical and biotechnological product development, from research and pre-clinical trials to regulatory approvals and post-market studies, supporting organizations like research institutions, healthcare providers, and pharmaceutical companies. Key growth influencers in this market include advancements in genetic engineering, robust investments in biotechnology R&D, and a growing prevalence of chronic diseases necessitating innovative treatments. Opportunities abound in areas such as CRISPR technology, regenerative medicine, and bioinformatics; stakeholders can harness these by investing in collaborative partnerships, enhancing service portfolios, and focusing on emerging markets. Nonetheless, limitations persist, such as stringent regulatory landscapes, high operational costs, and ethical concerns around genetic modifications, which can impede market expansion. Additionally, access to skilled professionals and data management challenges present significant hurdles. Innovative research areas with high potential for business growth include developing affordable sequencing methods, improving bioprocessing efficiencies, and integrating AI and machine learning for predictive analytics in drug discovery. For market entrants and existing players, insights into market dynamics reveal a promising but competitive landscape where adaptability, technological prowess, and strategic alliances will be essential for sustained growth. Emphasizing patient-centric approaches and sustainability practices may also offer distinct advantages in line with global trends towards eco-conscious and human-centered healthcare solutions. Overall, the biotechnology services market presents a vibrant environment ripe with potential for those ready to navigate its complexities with innovative strategies.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Biotechnology Services Market

The Biotechnology Services Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing outsourcing of drug development activities by pharmaceutical companies
  • Growing rate of academic research activities and need for efficient facilities
  • Rising expansion of contract research and manufacturing services
• Market Restraints
  • Concerns over performance, quality and confidentiality of outsourcing services
• Market Opportunities
  • Advancements in biotechnology instruments and techniques
  • Emerging funding and investment activities in biotechnology research
• Market Challenges
  • Stringent regulatory compliances for biotechnology outsourcing services

Porter's Five Forces: A Strategic Tool for Navigating the Biotechnology Services Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Biotechnology Services Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Biotechnology Services Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Biotechnology Services Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Biotechnology Services Market

A detailed market share analysis in the Biotechnology Services Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Biotechnology Services Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Biotechnology Services Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Biotechnology Services Market

A strategic analysis of the Biotechnology Services Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Biotechnology Services Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., Almac Group Limited, AnaBioTec NV, Avance Clinical Pty Ltd., Azenta Life Sciences, Becton, Dickinson and Company, Biogen Inc., BioIVT LLC, Caidya, Catalent, Inc., Charles River Laboratories International, Inc., CMIC Group, Contract Pharmacal Corp., Crown Bioscience, Inc., Danaher Corporation, Eurofins Scientific Limited, GE HealthCare Technologies Inc., GenScript Biotech Corporation, ICON PLC, ITR Laboratories Canada, Kaneka Corporation, Laboratory Corporation of America Holdings, Merck KGaA, Novartis AG, Siemens Healthcare GmbH, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Biotechnology Services Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Service Type, market is studied across Cell Processing & Isolation, Donor Recruitment, Food Biotechnology Services, Prevention & Disease Control, Public Engagement Activities, and Tissue Collection.
• Based on End-Users, market is studied across Biotechnology Companies, Clinical Research Organizations(CROs), and Contract Manufacturers Organizations (CMOs).
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing outsourcing of drug development activities by pharmaceutical companies
    • 5.1.1.2. Growing rate of academic research activities and need for efficient facilities
    • 5.1.1.3. Rising expansion of contract research and manufacturing services
  • 5.1.2. Restraints
    • 5.1.2.1. Concerns over performance, quality and confidentiality of outsourcing services
  • 5.1.3. Opportunities
    • 5.1.3.1. Advancements in biotechnology instruments and techniques
    • 5.1.3.2. Emerging funding and investment activities in biotechnology research
  • 5.1.4. Challenges
    • 5.1.4.1. Stringent regulatory compliances for biotechnology outsourcing services
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Biotechnology Services Market, by Service Type

• 6.1. Introduction
• 6.2. Cell Processing & Isolation
• 6.3. Donor Recruitment
• 6.4. Food Biotechnology Services
• 6.5. Prevention & Disease Control
• 6.6. Public Engagement Activities
• 6.7. Tissue Collection

7. Biotechnology Services Market, by End-Users

• 7.1. Introduction
• 7.2. Biotechnology Companies
• 7.3. Clinical Research Organizations(CROs)
• 7.4. Contract Manufacturers Organizations (CMOs)

8. Americas Biotechnology Services Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Biotechnology Services Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Biotechnology Services Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
• 11.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Agilent Technologies, Inc.
• 2. Almac Group Limited
• 3. AnaBioTec NV
• 4. Avance Clinical Pty Ltd.
• 5. Azenta Life Sciences
• 6. Becton, Dickinson and Company
• 7. Biogen Inc.
• 8. BioIVT LLC
• 9. Caidya
• 10. Catalent, Inc.
• 11. Charles River Laboratories International, Inc.
• 12. CMIC Group
• 13. Contract Pharmacal Corp.
• 14. Crown Bioscience, Inc.
• 15. Danaher Corporation
• 16. Eurofins Scientific Limited
• 17. GE HealthCare Technologies Inc.
• 18. GenScript Biotech Corporation
• 19. ICON PLC
• 20. ITR Laboratories Canada
• 21. Kaneka Corporation
• 22. Laboratory Corporation of America Holdings
• 23. Merck KGaA
• 24. Novartis AG
• 25. Siemens Healthcare GmbH
• 26. Thermo Fisher Scientific Inc.